Oct 2, 2026 · 5 min listen · Last updated October 2, 2026
From storyflo. This is your daily audio brief. Hey, it's Chloe. October 2nd. Ten stories — one trial, three reviews, six takes you can actually use. Let's get into it. First, from STAT. Opinion: I treated heat stroke at the NYC Marathon.
Listen · storyflo · health and longevity
Daily Health & Wellness Brief · October 2nd
0:00-5:04
Pick your daily storyteller
Subscribe to match with Theo, Jessica, Chloe, Mason, Brock — your voice, every brief.
Daily Health & Wellness Brief · October 2nd · Storyflo
culture
Audio pre-rendered by Storyflo · cached + delivered from the edge
Opinion: I treated heat stroke at the NYC Marathon. Marathons need to prepare for a climate-changed world
Hey! So, I was reading about this doctor who volunteered at the NYC Marathon last year, and it was *hot*. Like, record-breaking hot. She was working in the medical tent, and around the three-and-a-half-hour mark, it just got slammed with runners who were really struggling.
She ended up treating a guy who collapsed right at the finish line. He was able to tell her his name, which is a good sign, but it was clear the heat was taking a serious toll on everyone, from elite athletes to recreational runners.
The whole experience really stuck with her, and it got her thinking about how marathons, and really all large outdoor events, need to start planning more seriously for a future where extreme heat is going to be more common because of climate change. It’s not just about having enough water anymore; it’s about fundamentally rethinking how these events are managed when the weather gets dangerous.
Opinion: The law has to catch up on orphan-designated drugs with multiple uses
Hey! So, I was reading about this thing with drug approvals, and it made me think of you. Basically, there's this one drug, Rinvoq, that's approved for a few different conditions, like Crohn's disease and juvenile idiopathic arthritis. The problem is, the way the government classifies drugs can sometimes be a bit… well, clunky.
See, when a drug gets "orphan drug" status, it's usually because it's for a rare disease. This status comes with certain benefits, like tax credits and a period of market exclusivity, meaning other companies can't sell a generic version for a while. This is super helpful for getting rare disease treatments developed.
But here's where it gets tricky. Rinvoq is approved for both rare diseases and more common ones. The law, as it stands, doesn't always account for drugs that have multiple uses, especially when one of those uses is for a more common condition. The author of this piece, who's a pharmacist, points out that this can create some weird situations.
For example, the market exclusivity that comes with orphan drug status might be applied even when the drug is being used for a condition that isn't rare. This can delay the availability of cheaper generic versions for patients who need the drug for those more common conditions, which seems a bit unfair, right? It’s like the law hasn't quite caught up with how these drugs are actually being used in practice.
STAT+: NIH awarded all its grant funding, but delayed and opaque decisions stymied researchers
Hey! So, I was just looking at this STAT analysis about the NIH's grant funding for the last fiscal year, and it's a bit of a mixed bag. The big takeaway is that they did end up spending all their allocated grant money, which is good, but the way they got there is causing some real headaches for researchers.
Apparently, the whole process was really slow and kind of unclear. Researchers are saying these delays are making it tough to get their work done and even to come up with new, exciting research ideas. It feels like the uncertainty is really slowing things down.
They also funded fewer projects overall compared to previous years. It looks like the NIH might have prioritized fully funding some of those bigger, multi-year grants upfront, which then left less money available for new awards. So, fewer grants are going out the door.
Interestingly, the analysis also noted that the agency continued to reduce grants focused on health disparities, race, and ethnicity. On the flip side, they didn't make much headway on other goals, like spreading funding more evenly across the country or giving more support to scientists just starting out in their careers. It's definitely something to keep an eye on.
Apple season brings a special joy, and it’s a time when many people celebrate the fruit's versatility. From pies to ciders, apples are a staple in fall recipes. Interestingly, recent studies suggest that apples might also offer some health benefits. They’re rich in fiber and antioxidants, which can support heart health and potentially lower the risk of chronic diseases.
One study highlighted that regular apple consumption is linked to improved gut health due to their fiber content, which helps maintain a healthy digestive system. Plus, the antioxidants found in apples can help combat oxidative stress, making them a smart addition to your diet.
So, if you’re looking for a tasty and nutritious snack this season, reaching for an apple might be a great choice. Whether you enjoy them fresh, baked, or in a warm cider, they can be a delightful part of your fall routine.
In a world that often feels overwhelming, it’s important to focus on the good things. Acknowledging positive moments can help balance the heaviness we sometimes experience. The author reflects on their own journey, realizing that if we only dwell on the tough stuff, we miss out on joy.
This week, they enjoyed a lovely walk with a friend, which is always uplifting. They also scored the last butternut squash at the store, just in time for a soup recipe they were excited about. Lastly, they took a moment to appreciate sunflowers, a simple yet beautiful reminder of nature's brightness.
The piece wraps up with an invitation to share good things, reinforcing the idea that celebrating small joys can make a big difference.
This creamy dip combines shredded chicken, crispy bacon, roasted garlic, and plenty of cheese, all spiced up with jalapeños. It’s perfect for dipping with tortilla chips, but honestly, you can enjoy it straight from the dish if you prefer.
For the chicken, shredded rotisserie is a great shortcut, but you can also use two cooked chicken breasts if you have them on hand. A tip: save any bacon grease for future recipes to add extra flavor. While you can swap in garlic powder for the roasted garlic, the latter really enhances the taste.
To make this dip, you’ll need three jalapeños, sliced green onions, eight to ten diced bacon slices, and your choice of chicken. It’s a simple yet satisfying dish that’s sure to be a hit at any gathering. Enjoy!
Many Medicare Part D Stand-Alone Drug Plan Enrollees Will See Modest Premium Increases for 2027, But Others Could Pay Much More If They Don’t Switch Plans
In 2027, many people enrolled in Medicare Part D stand-alone drug plans will face small premium increases, typically under $10 a month. However, for those who stick with their current plans without switching, they could see their premiums jump by $50 or more. The overall number of these plans is expected to decrease slightly, which may affect options for some enrollees. It’s a good reminder for everyone to review their plans and consider their choices, especially if they want to avoid those bigger price hikes. Staying informed can really make a difference in managing costs.
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to storyflo · health and longevity.